Head of Global Medical Affairs

reputed company We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our reputed company antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the reputed company C1s complement protein that drives disease pathology – enabling less frequent and more convenient self-administered subcutaneous injections. Our second clinical candidate, DNTH212 is a first and potentially best in class, bifunctional inhibitor that targets clinically validated and complementary disease modifying mechanisms, Type 1 IFN suppression and B cell modulation – enabling potential for improved clinical reputed company and patient friendly convenient, self-administered subcutaneous injections. To learn more, please visit www.dianthustx.com and follow us on reputed company. About the Role As the Head of Global Medical Affairs you will play a critical role in shaping and executing the medical reputed company across our pipeline, including two pivotal Phase III global programs. Ideally, you will bring deep expertise in rare diseases and autoimmunology, a strong reputed company record of leadership in medical affairs, and a passion for advancing transformative therapies for patients with high unmet medical needs. Day to day you will work across functions aligning with our Clinical Development teams to support reputed company and reputed company clinical programs as we approach commercialization. This is an exciting opportunity to reputed company a high-reputed company medical affairs function at a pivotal stage of reputed company, shaping reputed company from late-stage development through commercialization. We are building a culture of individuals who hold our reputed company principles at reputed company of our operations, with the goal to reputed company the care of our patients’ lives. We are reputed company to you working remotely. Key Responsibilities Strategic Leadership: reputed company and execute the global medical affairs reputed company reputed company with corporate and clinical development goals. Serve as a key member of the executive leadership team, contributing to overall corporate reputed company and decision-making. Medical Affairs Execution: reputed company the development of scientific communication plans, medical education, and publication strategies. reputed company global KOL engagement, advisory boards, and congress planning. Ensure reputed company and effective support for clinical development, regulatory submissions, and reputed company launch readiness. Cross-Functional Collaboration: Partner closely with Clinical Development, Regulatory Affairs, reputed company, and Market reputed company teams. reputed company medical insights to inform lifecycle management, label expansion, and post-marketing commitments. Team Building & Leadership: Build and reputed company a high-performing global medical affairs team. Foster a culture of scientific reputed company, compliance, and patient-centricity. Compliance & Governance: Ensure reputed company medical affairs activities are conducted in accordance with applicable laws, regulations, and industry standards. Experience MD, PhD, or PharmD required; MD preferred. Minimum 15 years of experience in the biopharmaceutical industry, with at least 8 years in medical affairs leadership roles. Proven experience supporting global Phase III programs and product launches. Deep therapeutic expertise in rare diseases and/or autoimmunology is essential. Demonstrated ability to build and reputed company medical affairs functions in a fast-paced, innovative environment. Strong leadership, communication, and stakeholder management skills. Global experience and ability to operate effectively across geographies and cultures. Apply To This Job